|
Reliance Industries Limited
|
|
POLYPROPYLENE
|
| REPOL H029SG |
HOMOPOLYMER |
| |
| Product description &
applications : |
Features : |
|
REPOL Polypropylene H029SG is manufactured using Unipol
PP process which combines the production efficiency
of gas phase fluidized bed reactor technology with the
high activity and stereo specificity of the SHAC catalyst
system.
REPOL H029EG is recommended for use in
oriented (OPP) film Process. Repol H029SG is the material
of choice for BOPP films used in adhesive tapes, food
packaging, cigarette & textile overwraps, lamination
, synthetic paper etc.
|
Repol H029SG
is designed to provide
- High tensile strength
- Excellent gloss and clarity
- Good processability
|
| |
| Typical properties
of Repol H029SG are as follows: |
| |
| Property |
ASTM Test
Method |
Unit |
Typical Value*. |
| Melt flow index,(230oc/2.16Kg) |
D 1238 |
g/10 min |
2.9 |
| Tensile Strength
at yield (50 mm/min ) |
D 638$ |
MPa |
36 |
| Elongation at
yield (50 mm/min ) |
D 638$ |
% |
8 |
| Flexural modulus
(1% secant) |
D 790A$ |
MPa |
1660 |
| Notched izod
impact strength (23oc) |
D 256$ |
J/m |
40 |
| Heat deflection
temperature (455 kPa) |
D 648 |
oC |
104 |
| |
| |
|
$ : ASTM D638 Type I specimen injection moulded and
tested in accordance with ASTM D4101.
|
|
|
|
Repol H029SG meets the requirements stipulated in IS
10910-1984 on on "Specification for Polypropylene and
its copolymers for safe use in contact with foodstuffs,
pharmaceuticals, and drinking water". Additives incorporated
in this grade conform to the positive list of constituents
as prescribed in IS-10909-1984.The grade and the additives
incorporated in it also comply with the FDA:CFR Title
21, 177.1520, Olefin polymers.
|
|
|
|
REPOL is the registered trademark for Polypropylene
from Reliance Industries Limited
|
|
|
|
* Typical valuesw with injection moulded specimens,
not to be taken as specification
|
|
The data, information and suggestions contained contained
herein are given purely as a guide. Reliance Industries
Limited and Reliance Group Companies undertake no responsibility
either for the results deriving from their adoption
or for possible position in apparent contrast with existing
patent rights.
|